Understand the source comparison
SS-31 Stacking Comparison: Pathway Compatibility Analysis
GH Secretagogues (CJC-1295, Ipamorelin) JAK-STAT signaling, pulsatile GH release Indirect. Increases anabolic ATP demand 6–8 hours post-administration High. Mechanisms don't compete when sequenced SS-31 morning, GH peptides evening Compatible with temporal sep
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GH Secretagogues (CJC-1295, Ipamorelin)
- JAK-STAT signaling, pulsatile GH release
- Indirect. Increases anabolic ATP demand 6–8 hours post-administration
- High. Mechanisms don't compete when sequenced
- SS-31 morning, GH peptides evening
- Compatible with temporal separation; monitor recovery metrics during loading phase
- Cognitive Enhancers (Dihexa, Cerebrolysin)
- BDNF upregulation, neurotrophic signaling
- Minimal. Operates in synaptic and nuclear compartments
- Very High. No direct mitochondrial stress
- Can co-administer; no separation required
- Excellent stacking candidate; synergistic for neuroprotection research
- Thymic Peptides (Thymalin)
- T-cell differentiation, immune modulation
- None. Lymphoid tissue-specific
- Very High. Completely separate pathways
- Can co-administer
- Ideal for immune-mitochondrial aging protocols; no pathway interference
- Metabolic Peptides (AOD-9604, Fragment 176-191)
- Lipolysis stimulation, fat oxidation
- Moderate. Increases mitochondrial fatty acid flux
- Moderate. Requires dose titration
- Stagger by 4–6 hours; start one compound first
- Monitor for fatigue; reduce doses during co-administration if ATP demand signals appear
- Thermogenic Compounds (Tesofensine)
- Triple monoamine reuptake inhibition
- High. Acute elevation of mitochondrial ATP demand
- Low. Compounding stress on electron transport
- Not recommended for simultaneous use
- High risk of transient ATP insufficiency; separate by 8+ weeks if both required
- Mitochondrial Antioxidants (MitoQ, SkQ1)
- Direct ROS scavenging in mitochondrial matrix
- High. Competes for cardiolipin binding sites
- Low. Redundant mechanisms reduce efficacy
- Choose one or the other, not both
- SS-31 preferred for cardiolipin stabilization; MitoQ better for matrix ROS if cardiolipin intact